Limited agreement of cytokines and CRP through patient-centric microsampling compared to venipuncture in healthy adults
Tuttle et al.
The finding, in our words
The study found that although participants preferred patient-centric microsampling devices for home use, the agreement with venous plasma for measuring CRP and cytokines was inconsistent, indicating that further validation is required before these methods replace standard venipuncture.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
A study of 292 patients found that the slopes of home-collected stimulated dried blood spot C-peptide levels over six months predicted 12-month venous mixed-meal tolerance test results, P<0.001. This shows decentralised microsampling can monitor beta-cell function, though further validation is required to confirm its reliability and broader applicability.
Older adults achieved 98% adherence when self-collecting dried blood spots at home for inflammatory markers, with 97% of samples yielding valid results. Test-retest reliability was good (ICCs 0.70–0.76) and correlation with venous blood was strong (r=0.60–0.99), demonstrating that remote capillary sampling is a feasible and valid method for decentralised assessment of inflammation in older adults.
Self collected dried blood spots gave equivalent results to venous blood for lipids, HbA1c and C reactive protein, enabling similar classification of cardiovascular risk; self collection had lower response than nurse collection but similar demographic participation.
In a decentralised design, HAE patients collected dried blood spot samples at home during attacks and at clinic visits, with high acceptability and sufficient sample volumes for LC-IM-QToF MS metabolomics, supporting the feasibility of patient-centric microsampling to discover disease activity biomarkers.
Capillary dried blood spots, after haematocrit-dependent conversion, showed good agreement with plasma for 25-hydroxyvitamin D quantification, with 90 per cent of results within 20 per cent of plasma and substantial to almost perfect agreement in status classification, supporting reliable home self-collection for large-scale vitamin D monitoring.